Ralexar Therapeutics
Ralexar Therapeutics focuses on the development of an innovative portfolio of liver X receptor agonists.
Ralexar Therapeutics operates in biotechnology, clinical trials, therapeutics based in Greater Philadelphia Area, Great Lakes, Northeastern US, founded in 2013.
As a business in biotechnology, clinical trials, therapeutics, Ralexar Therapeutics is listed here with the public details available about it.
Its base of operations is Greater Philadelphia Area, Great Lakes, Northeastern US.
It is recorded at the Series_Unknown stage.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $41.6M in funding.
| Sector | Biotechnology, Clinical Trials, Therapeutics |
|---|---|
| Headquarters | Greater Philadelphia Area, Great Lakes, Northeastern US |
| Founded | 2013 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $41,645,191 |
Website: www.ralexar.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account